We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
(-3.4%)
Cap. Flow
-$21B
Cap. Flow
% of AUM
-11.12%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$826M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$813M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$305M |
| 4 |
Microsoft
MSFT
|
+$261M |
| 5 |
Pinterest
PINS
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.27B |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$1.08B |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$1.02B |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$843M |
| 5 |
Linde
LIN
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.66% |
| 2 | Healthcare | 11.06% |
| 3 | Financials | 8.17% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Communication Services | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Haemonetics
HAE
$3.88B
| $5.13M | ﹤0.01% |
76,938
+17,304
| +29% | +$1.22M |
|
2027
Trupanion
TRUP
$1.09B
| $5.13M | ﹤0.01% |
44,588
+3,422
| +8% | +$298K |
|
2028
Gevo
GEVO
$355M
| $5.12M | ﹤0.01% |
704,194
-151,334
| -18% | -$1.11M |
|
2029
Flywire
FLYW
$2.05B
| $5.11M | ﹤0.01% |
+138,968
| New | +$4.66M |
|
2030
PUT
Etsy
ETSY
$7.89B
| $5.11M | ﹤0.01% |
24,800
-27,500
| -53% | -$5.09M |
|
|
WPF
2031
DELISTED
Foley Trasimene Acquisition Corp.
WPF
| $5.1M | ﹤0.01% |
+512,900
| New | +$5.21M |
|
|
KW
2032
DELISTED
Kennedy-Wilson Holdings
KW
| $5.1M | ﹤0.01% |
257,549
-2,677
| -1% | -$54.1K |
|
2033
XP
XP
$8.8B
| $5.09M | ﹤0.01% |
116,966
-51,983
| -31% | -$2.15M |
|
2034
PUT
Simon Property Group
SPG
$74.3B
| $5.08M | ﹤0.01% |
38,800
-185,700
| -83% | -$23.1M |
|
2035
Eagle Materials
EXP
$6.59B
| $5.08M | ﹤0.01% |
36,058
-15,070
| -29% | -$2.17M |
|
|
GTLS
2036
DELISTED
Chart Industries
GTLS
| $5.08M | ﹤0.01% |
34,732
-2,053
| -6% | -$301K |
|
|
SI
2037
DELISTED
Silvergate Capital Corporation
SI
| $5.06M | ﹤0.01% |
45,118
+36,765
| +440% | +$4.16M |
|
2038
PUT
Cigna
CI
$74.5B
| $5.04M | ﹤0.01% |
21,300
+18,400
| +634% | +$4.6M |
|
2039
Flowers Foods
FLO
$1.53B
| $5.04M | ﹤0.01% |
209,543
-42,550
| -17% | -$1.03M |
|
2040
CareTrust REIT
CTRE
$9.74B
| $5.04M | ﹤0.01% |
216,817
+5,607
| +3% | +$132K |
|
2041
Alarm.com
ALRM
$2.75B
| $5.01M | ﹤0.01% |
59,202
-19,990
| -25% | -$1.71M |
|
2042
ACM Research
ACMR
$5.7B
| $5.01M | ﹤0.01% |
147,162
-78,009
| -35% | -$2.14M |
|
|
GTM
2043
CALL
ZoomInfo Technologies
GTM
$1.05B
| $5.01M | ﹤0.01% |
96,000
+50,600
| +111% | +$2.38M |
|
2044
Performance Food Group
PFGC
$18B
| $5.01M | ﹤0.01% |
105,495
-4,248
| -4% | -$224K |
|
2045
HUTCHMED
HCM
$2.01B
| $5M | ﹤0.01% |
127,268
-91,624
| -42% | -$2.65M |
|
2046
PUT
Viasat
VSAT
$11.9B
| $4.98M | ﹤0.01% |
+100,000
| New | +$4.97M |
|
|
NVTA
2047
PUT
DELISTED
Invitae Corporation
NVTA
| $4.98M | ﹤0.01% |
146,100
+15,000
| +11% | +$488K |
|
2048
Sabre
SABR
$779M
| $4.98M | ﹤0.01% |
398,771
-156,692
| -28% | -$2.2M |
|
2049
Hanover Insurance
THG
$8.09B
| $4.98M | ﹤0.01% |
36,575
-7,957
| -18% | -$1.09M |
|
|
ROIC
2050
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $4.97M | ﹤0.01% |
281,749
+13,684
| +5% | +$241K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2021 Portfolio in Review
As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.
- Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
- Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
- Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
- Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
- Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
- Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
- Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.
Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.